Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment

Gastrointestinal Endoscopy

Volumn 71, Issue 1, 2010, Pages 28-34

  Poh, Choo Hean ^a   Gasiorowska, Anita ^a   Navarro Rodriguez, Tomas ^a   Willis, Marcia R ^a   Hargadon, Deborah ^a   Noelck, North ^a   Mohler, Jane ^a   Wendel, Christopher S ^a   Fass, Ronnie ^a  

^a The Neuroenteric Clinical Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS DISEASE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; TREATMENT FAILURE;

EID: 73249149648     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.08.024     Document Type: Article

References (32)

1. Fass R., Shapiro M., Dekel R., et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next?. Aliment Pharmacol Ther 22 (2005) 79-94
2. Carlsson R., Dent J., Watts R., et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GERD Study Group. Eur J Gastroenterol Hepatol 10 (1998) 119-124
3. Inadomi J.M., Jamal R., Murata G.H., et al. Step-down management of gastroesophageal reflux disease. Gastroenterology 121 (2001) 1095-1100
4. Fass R., and Gasiorowska A. Refractory GERD. What is it?. Curr Gastroenterol Rep 10 (2008) 252-257
5. Fass R., and Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 58 (2009) 295-309
6. Bautista J.M., Wong W.M., Pulliam G., et al. The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications. Dig Dis Sci 50 (2005) 1909-1915
7. Sifrim D., Castell D.O., Dent J., et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53 (2004) 1024-1031
8. Vela M.F., Camacho-Lobato L., Srinivasan R., et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120 (2001) 1599-1606
9. Hirano I., Zhang X., Pandolfino J.E., et al. Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 3 (2005) 1083-1088
10. Tack J., Koek G., Demedts I., et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?. Am J Gastroenterol 99 (2004) 981-989
11. Charbel S., Khandwala F., and Vaezi M.F. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 100 (2005) 283-289
12. Richter J.E. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 658-664
13. Lichtenstein D.R., Cash B.D., Davila R., et al. Standards of Practice Committee. Role of endoscopy in the management of GERD. Gastrointest Endosc 66 (2007) 219-224
14. Wo J.M., Mendez C., Harrell S., et al. Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease. Am J Gastroenterol 99 (2004) 2311-2316
15. Brazier J.E., Harper R., Jones N.M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305 (1992) 160-164
16. Jenkinson C., Coulter A., and Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 306 (1993) 1437-1440
17. Locke G.R., Talley N.J., Weaver A.L., et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 69 (1994) 539-547
18. Lundell L.R., Dent J., Bennett J.R., et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45 (1999) 172-180
19. Sampliner R.E. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
20. Wakelin D.E., Al-Mutawa T., Wendel C., et al. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 58 (2003) 350-355
21. Gupte A.R., and Draganov P.V. Eosinophilic esophagitis. World J Gastroenterol 15 (2009) 17-24
22. Shaheen N.J., and Richter J.E. Barrett's oesophagus. Lancet 373 (2009) 850-861
23. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55 (2006) 1398-1402
24. Hirano I., and Richter J.E. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 102 (2007) 668-685
25. Hemmink G.J., Bredenoord A.J., Weusten B.L., et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?. Am J Gastroenterol 103 (2008) 2446-2453
26. Peghini P.L., Katz P.O., Bracy N.A., et al. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 93 (1998) 763-767
27. Orr W.C., and Harnish M.J. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity. Aliment Pharmacol Ther 17 (2003) 1553-1558
28. Hetzel D.J., Dent J., Reed W.D., et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95 (1988) 903-912
29. Gonsalves N., Policarpio-Nicolas M., Zhang Q., et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 64 (2006) 313-319
30. Richter J.E. The patient with refractory gastroesophageal reflux disease. Dis Esophagus 19 (2006) 443-447
31. Bredenoord A.J., and Smout A.J. Refractory gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol 20 (2008) 217-223
32. Wang K.K., and Sampliner R.E. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103 (2008) 788-797